Early Proteomic and Metabolic Signatures of Liver and Eye in OAT-Deficient Mice

This study utilizes quantitative proteomic and metabolomic profiling of OAT-deficient mice to reveal that while the liver compensates for ornithine accumulation through enhanced urea cycle activity, the eye—specifically the RPE/choroid—exhibits extensive early molecular disruptions in mitochondrial metabolism, cytoskeleton, and antioxidant capacity that explain its selective vulnerability in gyrate atrophy.

The Gist

The Big Picture: A Broken Factory and a Failing Power Plant

Imagine your body is a massive, bustling city. In this city, there is a specific worker named OAT (Ornithine Aminotransferase). OAT's job is to act as a traffic controller at a busy intersection where three major highways meet: the "Waste Removal" highway (Urea Cycle), the "Energy" highway (TCA Cycle), and the "Building Materials" highway (Amino Acids).

In people and mice with a rare eye disease called Gyrate Atrophy (GA), the OAT worker is missing. Because the traffic controller is gone, a specific type of waste called Ornithine starts piling up like a massive traffic jam.

For a long time, doctors knew this waste built up in the blood, but they didn't understand why it specifically destroyed the eyes while leaving the rest of the body mostly okay. This study is like sending a team of detectives into the city's Liver (the waste processing plant) and the Eye (the power plant) to see what happens before the lights go out. They looked at the city while it was still running, just before the damage became visible.

---

The Three Neighborhoods Investigated

The researchers looked at three specific "neighborhoods" in the mouse city:

1. The Liver: The main recycling and detox center.
2. The Retina: The "film" of the eye that captures images.
3. The RPE/Cho: The "solar panel and battery backup" layer behind the film. This layer feeds the retina and keeps it powered.

Here is what they found in each neighborhood:

1. The Liver: The Overworked Recycling Plant

When the OAT worker is missing, the liver tries to be a hero. It sees the traffic jam of Ornithine and says, "I'll handle this!"

• The Analogy: Imagine a recycling plant that suddenly gets flooded with a specific type of plastic it can't usually process. The plant workers (enzymes) go into overdrive, trying to burn it off or convert it into something else.
• What Happened: The liver changed its entire operation. It started working harder to detoxify the waste and even changed its "blueprints" (DNA/chromatin) to handle the stress. It was like the factory manager rewriting the employee handbook to deal with a crisis.
• The Catch: While the liver was busy fighting the fire, it started using up its own energy reserves (sugar and antioxidants) to do the job.

2. The Retina: The Quiet Film Strip

Surprisingly, the actual film strip of the eye (the Retina) didn't change much yet.

• The Analogy: Think of the retina as a movie screen. Even though the power plant next door is having trouble, the screen itself is still displaying the picture clearly.
• What Happened: The retina was smart. It realized it couldn't get its usual fuel (glutamate) from the broken traffic controller, so it started eating its own "emergency rations" (other amino acids) to keep the lights on. It was a quiet, desperate survival mode, but the screen hadn't cracked yet.

3. The RPE/Cho: The Failing Power Plant (The Real Problem)

This is where the real trouble started. The RPE/Cho is the layer that powers the retina. It's like the battery and solar panel combined.

• The Analogy: Imagine a high-tech power plant that suddenly loses its main generator. The workers (mitochondria) start collapsing, the delivery trucks (cytoskeleton) stop moving, and the building's walls (structural proteins) start crumbling.
• What Happened: This area showed the most damage of all.
  • The Batteries Died: The tiny power generators inside the cells (mitochondria) stopped working efficiently.
  • The Scaffolding Collapsed: The internal structure of the cells fell apart.
  • The Antioxidant Shield Cracked: The cells lost their ability to fight off rust and corrosion (oxidative stress).
  • The Fuel Shortage: They ran out of "creatine," a molecule that acts like a battery charger for high-energy cells.

The Common Thread: The "Methyl" Shortage

There was one thing that happened in all three neighborhoods: a shortage of Methyl groups.

• The Analogy: Think of "methylation" as the city's mail system. It sends little sticky notes to different parts of the cell to tell them what to do (like "turn on this gene" or "fix this protein").
• The Problem: Because the Ornithine traffic jam was so bad, the city used up all its "sticky notes" (S-adenosylmethionine or SAM) to try to build polyamines (another type of molecule).
• The Result: The mail system broke down. The cells stopped getting their instructions. This happened in the liver, the retina, and the power plant, but the power plant (RPE/Cho) was the one that couldn't recover from the lack of instructions.

The "Aha!" Moment

The biggest discovery of this paper is that the eye doesn't fail because the waste is toxic; it fails because the power plant runs out of fuel and instructions.

Even though the liver is working hard to clean up the mess, the RPE/Cho (the eye's power plant) is the most fragile. It relies heavily on a specific type of fuel (proline) and a specific battery system (mitochondria) that the OAT deficiency destroys.

What Does This Mean for the Future?

This study is like finding the exact moment a house starts to burn down, rather than waiting until the roof collapses.

• Old Thinking: "We need to lower the Ornithine levels in the blood." (Trying to stop the fire at the source).
• New Thinking: "We also need to protect the Power Plant." (Giving the RPE/Cho extra batteries, better fuel, and fixing the mail system).

The researchers suggest that future treatments shouldn't just try to clean up the blood. We might need to give the eyes specific "emergency kits"—like extra creatine, antioxidants, or proline—to keep the power plant running even while the traffic jam is being cleared.

In short: The liver is the firefighter trying to put out the blaze, but the eye's power plant is the one that's actually burning down. To save the vision, we need to help the power plant survive the fire.

Technical Summary

1. Problem Statement

Gyrate Atrophy (GA) is a rare, autosomal recessive blinding disorder caused by mutations in the Ornithine Aminotransferase (OAT) gene. OAT is a mitochondrial enzyme that converts ornithine to pyrroline-5-carboxylate (P5C) and glutamate, linking the urea cycle, TCA cycle, and amino acid metabolism.

• Clinical Paradox: While OAT deficiency causes massive systemic hyperornithinemia (10–20x elevation in plasma), the pathology is predominantly ocular (chorioretinal atrophy), with rare systemic neurological or muscular symptoms.
• Knowledge Gap: The mechanisms driving the selective vulnerability of the eye despite high systemic ornithine levels remain undefined. Furthermore, it is unclear whether the liver (the primary site of ornithine disposal) or ocular tissues undergo specific molecular changes prior to the onset of visible retinal degeneration.
• Therapeutic Context: Current treatments (arginine-restricted diet, supplements) are only partially effective. Recent gene therapy studies suggest that restoring OAT in both liver and retina is necessary for full recovery, implying that local tissue-specific metabolic failures contribute to the disease.

2. Methodology

The study utilized an integrated multi-omics approach (proteomics and metabolomics) on a mouse model of GA (Oat^rhg/rhg) at an early, pre-degenerative stage.

• Animal Model: 3.5-month-old homozygous Oat^rhg/rhg mice (recapitulating GA biochemistry) and heterozygous littermate controls (Oat^rhg/+). At this age, mice have normal ERG function and retinal structure, allowing the capture of early molecular signatures before overt damage.
• Tissues Analyzed: Liver, Neural Retina, and Retinal Pigment Epithelium/Choroid (RPE/Cho).
• Proteomics:
  • Technique: Data-Independent Acquisition (DIA) mass spectrometry on an Orbitrap Exploris 480.
  • Analysis: Quantitative profiling using EncyclopeDIA and Scaffold DIA. Differential expression (DE) defined as |log2FC| ≥ 1 and adjusted p < 0.05. Pathway enrichment via STRING and DAVID.
• Metabolomics:
  • Technique: Targeted LC-MS/MS (MRM mode) on a QTRAP 5500.
  • Analysis: Quantification of 144 (liver), 126 (retina), and 136 (RPE/Cho) metabolites. Statistical analysis via PLS-DA and KEGG pathway enrichment.
• Validation: Western blotting confirmed the absence of OAT protein in mutant tissues.

3. Key Results

A. Common Metabolic Signatures Across Tissues

• Ornithine Accumulation: Confirmed massive accumulation of ornithine (>20-fold) in all three tissues.
• SAM/Methylation Disruption: A consistent reduction in N(6)-methyl-lysine was observed in liver, retina, and RPE/Cho. This suggests that excess ornithine is shunted into polyamine synthesis, depleting S-adenosylmethionine (SAM) and impairing methylation capacity across all tissues.

B. Tissue-Specific Responses

1. Liver (Metabolic Compensation & Detoxification)

• Proteomics: 62 DE proteins. Enrichment in detoxification enzymes (Cytochrome P450s, Sulfotransferases) and histone variants (H2B).
• Metabolomics: Increased ornithine and citrulline indicate enhanced urea cycle flux to dispose of excess ornithine.
• Adaptation: Upregulation of betaine (to support SAM regeneration) and histone demethylases (KDM3B).
• Implication: The liver actively compensates for OAT loss by rerouting ornithine through the urea cycle and adjusting epigenetic regulation, but this comes at a cost to detoxification capacity and redox homeostasis (reduced glutathione).

2. Retina (Metabolic Reprogramming for Glutamate)

• Proteomics: Minimal changes (only 5 DE proteins), primarily involving cytoskeletal and synaptic modulation.
• Metabolomics: Significant reprogramming of amino acid catabolism.
  • Reduction: Branched-chain amino acids (BCAAs), lysine, and arginine.
  • Mechanism: The retina appears to catabolize these amino acids to generate glutamate and TCA cycle intermediates (succinyl-CoA, acetyl-CoA).
• Implication: The retina prioritizes maintaining the glutamate pool (essential for neurotransmission and the malate-aspartate shuttle) by sacrificing other amino acid pathways, rather than undergoing massive proteomic remodeling.

3. RPE/Choroid (The Primary Site of Early Failure)

• Proteomics: The most extensive changes (254 DE proteins).
  • Downregulation: Mitochondrial proteins (ETC components, transporters like TOM22), ribosomal subunits, and enzymes for creatine synthesis (KCRS).
  • Upregulation: Crystallins (stress response) and keratins.
• Metabolomics: Reduced levels of carnosine (antioxidant), myo-inositol (membrane signaling), and creatine derivatives.
• Implication: The RPE/Cho suffers early mitochondrial dysfunction, loss of bioenergetic capacity, and structural instability (cytoskeletal/ECM remodeling). This tissue lacks the metabolic compensation seen in the liver and is the likely "bottleneck" for retinal health.

C. Cross-Tissue Comparison

• Proteomic Overlap: Aside from OAT itself, only 6 proteins were consistently altered across all tissues. The pathways differed significantly: Liver focused on detoxification/nucleosome assembly; RPE/Cho focused on mitochondrial bioenergetics and cytoskeleton.
• Metabolic Overlap: Only two metabolites were shared across all tissues (increased ornithine, decreased N(6)-methyl-lysine). The retina showed the highest number of altered metabolites, suggesting it is the most metabolically vulnerable.

4. Key Contributions

1. Temporal Resolution: Identified molecular signatures prior to visual decline, distinguishing early adaptive responses from late-stage degeneration.
2. Tissue Specificity: Demonstrated that OAT deficiency triggers distinct, tissue-specific molecular cascades:
   • Liver: Metabolic compensation via the urea cycle and epigenetic remodeling.
   • Retina: Metabolic shunting to preserve glutamate.
   • RPE/Cho: Catastrophic failure of mitochondrial and structural integrity.
3. Mechanistic Insight into Selective Vulnerability: Provided evidence that the RPE/Cho is the primary site of damage due to its inability to compensate for mitochondrial dysfunction and SAM depletion, unlike the liver.
4. SAM/Polyamine Axis: Highlighted the depletion of SAM-dependent methylation (via polyamine synthesis) as a common, early pathological mechanism affecting chromatin structure and redox balance.

5. Significance and Clinical Implications

• Therapeutic Strategy: The findings support a dual-target approach for treating GA. Systemic therapies (e.g., liver-directed gene therapy or diet) alone may be insufficient because they do not address the intrinsic mitochondrial and structural failures in the RPE/Cho.
• Biomarkers: Early metabolic shifts (e.g., reduced carnosine, myo-inositol, and N(6)-methyl-lysine) could serve as biomarkers for disease progression before structural damage is visible.
• Supplementation Rationale: The data supports the use of proline (to bypass OAT block), creatine (to support mitochondrial energy), and carnosine (antioxidant) as potential adjunctive therapies to protect the RPE/Cho.
• Broader Impact: This study establishes a framework for understanding how metabolic enzyme deficiencies cause tissue-selective degeneration, relevant to other inherited metabolic disorders.

Data Availability: Proteomics data (PXD063614) and Metabolomics data (MSV000101103) are publicly available.